Petplan has been voted Best Insurance Provider in the seventh annual Your Cat and Your Dog Product Awards.
This is the sixth consecutive year Your Cat and Your Dog readers have voted Petplan number one, in response to a survey completed by thousands of pet owners.
Isabella von Mesterhazy, Head of Marketing at Petplan said: "To be independently voted number one provider by pet owners means so much, particularly as this is the sixth time we have been awarded this honour.
"Petplan's Covered for Life policy is the original lifetime policy - we were the first insurer to offer this type of policy and cover. This, combined with over 36 years' experience in the pet insurance marketplace means Petplan truly understands what pet owners need and want from their pet insurance. We settle 97% of claims successfully and 90% of customers renew each year. Moreover, we paid out over £180 million in claims in 2013, the majority directly with the vet, which leaves owners able to concentrate on supporting their pet back to full health rather than worrying about vet bills."
The CMA proposed that veterinary practices should be compelled to:
Most of these, along with the CMA's support for reform of the Veterinary Surgeons Act, have been welcomed not just by the BVA, but by the RCVS and the BVNA which also issued their responses on Friday.
The big sticking points, however, are the proposal that veterinary practices should cap prescription fees at £16, and that all practices should inform clients that they may buy medicines cheaper online.
The BVA argued that the proposed prescription price cap would be unlikely to reduce costs, and that 65% of vets who took part in its Voice of the Profession Survey said it would risk practice viability.
The proposal that vets should tell clients they can buy medicines cheaper online was more controversial, because of course two of the largest veterinary pharmacies are owned by corporate groups, and it is hard to think of any other area of business where small companies are legally required to direct customers to their corporate competitors.
BVA President Dr. Rob Williams MRCVS (pictured) said: “The measures outlined in the CMA’s provisional decision report are much more measured and proportionate compared to earlier proposals and that clearly shows they have listened to our concerns.
"As vets, we welcome the measures that increase transparency and help us to better support our clients.
"However, it’s vital that the CMA gets the detail right or it risks unintended negative consequences.
“BVA particularly welcomes the CMA backing our calls for reform of the outdated Veterinary Surgeons Act, including the need for practice regulation.
"Vets have been pressing for reform of this woefully outdated legislation for many years, and reform will go a long way to addressing many of the concerns raised throughout the CMA investigation and will help build trust with our clients.
“We do, however, have serious concerns about the medicines proposals – it is simply unreasonable to expect vet practices to actively promote online pharmacies, which are in direct competition for customers and some of which are run by large veterinary groups.
"In addition, the proposed £16 price cap for prescriptions will be ineffective and is unlikely to lead to lower vet bills for consumers.”
https://www.bva.co.uk/media/6641/bva-bsava-bvna-spvs-vmg-joint-response-to-cma-provisional-decision-report-final.pdf
Joint Care contains glucosamine, rosehip, echinacea, and vitamin C, and Supreme Petfoods says it's been developed in response to growing awareness of osteoarthritis (OA) as a significant yet under-diagnosed condition in small mammals.
Supreme points to a retrospective study which identified osteoarthritic lesions in 40% of domestic rabbits, with prevalence strongly correlated with age and body weight.¹
The company says that while definitive prevalence data in guinea pigs is lacking, OA is considered to be common in this species as well.²
Molly Varga, RCVS recognised exotics specialist, said: “Signs of joint pain are often subtle or masked in prey species.
"Proactive use of nutritional supplements like Science Selective Joint Care can help maintain mobility and may delay progression.
"Nutritional support, combined with appropriate husbandry and veterinary care, can make a real difference to long-term quality of life.”
As well as glucosamine, Science Selective Joint Care also contains rosehip, a botanical with claimed anti-inflammatory and chondroprotective properties and echinacea, which has claimed anti-inflammatory, antioxidant and immunomodulatory activity.3,4
Supreme says Vitamin C is an essential nutrient for guinea pigs and beneficial for rabbits, and contributes to normal collagen formation and may help protect joint tissues from oxidative stress.
Claire Hamblion, Marketing Director at Supreme Petfoods, said: “With 45% of pet owners now regularly purchasing supplements for their animals,5 the demand for clinically relevant, species-appropriate products is growing.
"We work closely with veterinary and nutrition experts to ensure our formulations meet emerging needs and Joint Care reflects that commitment.”
Available in 100g packs, Joint Care has a recommended retail price (RRP) of £6.99 and is suitable for rabbits, guinea pigs, and chinchillas.
https://supremepetfoods.com/products/science-selective-care-supplements
References
The Ageing Canine Toolkit, which was developed from research carried out by the University of Liverpool, aims to help both vets and owners provide the best care for senior and geriatric dogs.
It includes information about common health problems that affect ageing dogs and a colour-coded checklist to help owners know when to seek advice from a veterinary practice and how to guide discussions during consultations.
As part of the partnership, NationWide Laboratories will be distributing the toolkit to its clients, helping raise awareness and make sure that the owners of older dogs know how to look for signs of disease which could enable treatment to be started earlier.
Alison Selby, Fundraising Manager for BSAVA PetSavers said: “We are thrilled to be embarking on this partnership with NationWide Laboratories.
"By supporting the print and distribution costs of this invaluable resource, they will help us reach more pet owners across the UK.
"Working together in partnership, we hope to equip owners with the knowledge and confidence to support their dogs through the ageing process, ultimately improving their quality of life.”
https://bsava.com/petsavers/our-impact/citizen-science-project
Taking over the Presidency from Julian Hoad, David will continue to focus on the Programme of Change and the BSAVA’s new strategy, which includes some new products and services.
David qualified from the RVC in 1988 and has had a career largely in small animal practice, including a year in Canada.
He and his wife Rosie started the first feline-only practice in England and David is now an Advanced Practitioner in small animal dermatology.
He has postgraduate qualifications in small animal dermatology and medicine, becoming board certified in feline practice, and has an RCVS Fellowship on Feline Osteoarthritis.
David helped to set up the BSAVA West Midlands committee, before then becoming a BSAVA Council member and Chair of the Regions for three years before joining the Board and the presidential ladder.
David said: “It is an honour being BSAVA President for 2025-2026, but this next year will not be about me.
"It will be about the renewal of BSAVA, it will hear us shouting out with an ever-increasing voice about the most exciting innovations and I promise to do my very best.”
Julian Hoad will now move into the role of Senior Vice President, whilst Niall Connell begins his new role as Junior Vice President alongside Jo Megarity, who joins the Board as Honorary Treasurer.
The new study will examine the genetic changes that occur in osteosarcoma tumours.
By understanding which genes drive the disease, researchers hope to identify biomarkers – genetic clues that could help diagnose the cancer earlier, predict prognosis for individual patients, and ultimately lead to new treatment options.
The study is looking for dogs with a confirmed or suspected diagnosis of osteosarcoma, whose treatment plan includes surgical removal of the tumour at the QVSH.
With the owner’s permission, tissue samples will be collected from the amputated limb after surgery, as well as from nearby healthy tissue for comparison.
The researchers say participation involves no additional procedures, discomfort, or hospital visits for dogs, and there is no cost to owners for the research elements of the study.
Dr Louise Van Der Weyden, study co-lead at the Wellcome Sanger Institute, said: “Our new study aims to apply genomic sequencing techniques, which have benefited humans, to canine osteosarcoma to uncover what drives these bone tumours and gain a deeper understanding of why they happen.
"We hope that by doing so, we can pave the way for the development of potential biomarkers to help early diagnosis and possibly provide future treatment options for dogs who currently have no cure.”
https://www.hospital.vet.cam.ac.uk/news/new-research-improve-diagnosis-and-treatment-canine-osteosarcoma
oncology@vet.cam.ac.uk
Stephen was recognised for his services to veterinary education and animals in science.
He served as RCVS President from 2017 to 2018 and has been actively involved in the work of the College for many years, serving a total of 19 years as a Council member, both as a vet school-appointee and an elected member, before retiring in 2024.
During his time on Council, he led the Legislative Reform Working Group which developed the Legislative Reform Proposals, as well as the Graduate Outcomes Project, out of which the Veterinary Graduate Development Programme was developed.
Kulin was recognised for his services to animal health and international trade.
RCVS President, Linda Belton MRCVS, said: “Huge congratulations to both Professor May and Dr Patel on this outstanding achievement.
"Thank you both for your extraordinary contributions to the veterinary profession during your careers, for which I would like to extend my appreciation on behalf of everyone at the RCVS.
“I would also like to extend congratulations to all those mentioned in the King’s Birthday Honours List for contributions to the veterinary world, animal health and welfare, and to the One Health concept more generally.
"We could not do the work we do without vital stakeholder collaboration, and it is fantastic to see outstanding individuals in the field being recognised for all they have contributed to our society.”
This, says the company, highlights a missed opportunity for earlier cancer detection, which in turn limits the ability of veterinary teams to improve medical outcomes for their patients.
243 veterinary professionals took part in the survey, most of whom HT Vista says were general practitioners.
On average, they reported seeing 13.5 dermal and subcutaneous masses per vet per week, less than six of which lead to a diagnosis.
HT Vista says around 15% of these lumps will be malignant.
Veterinary oncologist Gillian Dank said: “Every week, thousands of dogs leave practices with undiagnosed masses.
"While many are benign, others are malignant, and delaying diagnosis can mean lost treatment opportunities and poorer prognoses.”
The number one reason why respondents said they don't test more widely is the assumption that a mass is benign by its gross characteristics, followed by owner concerns around cost, time constraints during consultations, and limited access to in-house cytology.
Vista HT Chief Commercial Officer Asher Fink and Managing Director Liron Levy-Hirsch will be presenting “20 dogs in your waiting room with lumps and bumps – how do you spot the 3 with cancer?" at the London Vet Show on 20th November from 1–1:50pm in Exhibitor Showcase Theatre 2
https://info.ht-vet.com/lump-and-bump-survey-results
https://www.cliniciansbrief.com/continuing-education/syllabus/lesson/cracking-code-lumps-bumps-fast-efficient-diagnosis-everyday-practice
https://london.vetshow.com/conference-programme-2025/session-title-coming-soon-38
Photo: www.depositphotos.com
The extension, which does not collect any data, interrupts searches related to a broad range of mental health and life challenges, including substance misuse, financial struggles, eating disorders, domestic abuse and more, with a positive message of hope and signposts to a variety of different mental health services.
According to R;ipple, its extension has now interrupted over 100,000 harmful online searches and 32 people so far say they are still alive today because the software intervened at a moment of crisis.
Nick Berryman from Agilio said: “Our commitment aligns with R;pple's mission to combat the stigma surrounding mental health and provide essential resources for those at risk.
"As part of this, we have implemented the tool across our own organisation to safeguard the wellbeing of our staff.
"In parallel, by supporting R;pple’s wider initiatives, we are helping to raise awareness and empower healthcare communities to take proactive steps in supporting those in need.”
R;ipple will be holding a live webinar on Tuesday 7th May at 1pm: Supporting workplace mental health and suicide prevention: my brother’s legacy.
In the webinar, R;ipple founder Alice Hendy MBE will draw on her experience of having lost her brother, Josh, to suicide in 2020 at the age of 21, and explain how healthcare organisations can create safer, more supportive environments through practical steps and awareness.
To register to attend, visit https://tinyurl.com/my-brother-s-legacy.
https://www.ripplesuicideprevention.com
https://agiliosoftware.com/
Purina says it is common for dogs with gastrointestinal disturbances not to digest fat properly1, resulting in water secretion in the gut and loose stools2, production of anti-inflammatory compounds2 and altered microbiome composition 3,4.
The company says a limited fat diet can help, but some conditions, such as hyperlipidaemia, require even lower fat levels, such as found in the new EN Low Fat diet.
If you go to stand P20 and watch a short video about the new diet, you'll be entered into a draw to with prizes which include shopping vouchers, gym bags and umbrellas.
Vets from the Purina Technical Support Line will also be on the stand to answer questions about the new product.
The installation is a collaboration between Vet Sustain and IVC Evidensia, supported by MSD Animal Health.
Laura Gelder-Robertson, CEO of Vet Sustain, said: “We want to show the best of what already exists within veterinary sustainability, to bring to life the business benefits for veterinary teams in a really hands-on, practical way that people can touch and feel and relate back to their everyday practice.
"This is a really positive news story where by sharing knowledge and collaborating across the profession, we can continually improve the health and wellbeing of animals, people, the environment and business.”
https://vetsustain.org/
HaemoVet haemostats are individually sterile packed in a variety of forms ranging from dental cubes, flex dressings and flowable powder.
Invicta says the range is affordably priced with dental cubes costing £1 each, packaged in 24 individual blistered packs with a three-year shelf life.
Rob Watkins, Managing Director of Invicta, said: “Most practice staff are familiar with using absorbable haemostats in routine and emergency surgery.
"However, statistics show that just 17% use them regularly1.
"Many staff cited price as a reason and this coupled with the rising costs of consumables spurred us to bring an affordable option to practices.”
The HaemoVet range comprises of sponges, powders or flowable syringes of gelatin matrix designed to provide rapid and safe haemostasis2.
For dental applications, there is also a sponge impregnated with colloidal silver.
Rob added: “The HaemoVet range provides practices with a much more affordable option and are carefully packaged in individual sachets to avoid waste to make it the economic and environmental product of choice.”
HaemoVet is available from Invicta Animal Health, which will also give training and information on its use.
T: 01403 791313Email: mail@invictavet.comW: invictavet.com/haemovet
Presenters at the webinar will include: Professor Melissa McDermid MD, MPH, division head, Occupational & Environmental Medicine, University of Maryland, Prof. Clare Knottenbelt BVSC MSC DSAM MRCVS, owner and founder of specialist referral service, Hawk and Dove, and previously clinical director of the Small Animal Hospital at the University of Glasgow Veterinary School, Sam Fontaine MSc, lecturer and director of the MSc Advanced Practice in Veterinary Nursing and module leader within the BVMS programme at The Glasgow School of Veterinary Medicine. There will also be a video from the oncology centre at The Queen’s Veterinary School, Cambridge University.
The webinar will also look at the use of Closed System Transfer Devices, such as Tevadaptor, to improve safety and break down barriers to treatment across all practices.
Clare Knottenbelt (pictured right) said: “Pets with cancer need to be able to access chemotherapy treatments locally. The advent of new closed administration systems mean that practices can now safely administer chemotherapeutics in house without the need for large investment, but still protecting the health of their staff."
Delegates will be able to to submit questions to the speakers and will receive a certificate for one hour of CPD. The session will be recorded so it can be watched again.
For the full programme or to register, visit: https://aesculap-academia.eventbritestudio.com/160802290981
Zoetis says AI Masses delivers fast, accurate, in-clinic screening of common lymph node and skin/subcutaneous masses in minutes, making Vetscan Imagyst the most capable veterinary AI analyser in the world.
AI Masses uses an algorithm to identify and classify common skin/subcutaneous mass and lymph node aspirates at the point of care.
At additional charge, for added diagnostic confidence, Zoetis also offers expert clinical pathologist reviews via Digital Cytology and Add-on Expert Review within hours.
Abhay Nayak, President, Global Diagnostics at Zoetis said: “By empowering veterinary teams with valuable insights into potentially cancerous cells, we are helping to reduce waiting times and alleviate stress for pet owners facing some of the most challenging moments with their beloved pets.
https://www.zoetisdiagnostics.com/uk/point-of-care
Camilla, who was shortlisted as a finalist for Innovator of the Year at the 2025 Digital Women Awards, says her mission has always been to give first-opinion vets the tools and confidence to get the most from ultrasound in everyday practice – and the new tool is a big step forward in that vision.
The tool:
Camilla says the final report is fully editable, but much of the “heavy lifting” is done — saving time, reducing second-guessing, and producing reports that are more useful for colleagues, clients, and patient care.
https://www.fovu.co.uk/
https://www.fovu.co.uk/fovu-report-video
WellVet suggests a variety of activities that practices might like to run, including coffee and chat sessions where everyone can sit together, have an informal chat and share experiences about the menopause.
That might provide a perfect opportunity for everyone to watch the WellVet animation which summarises the impact of the menopause on veterinary teams.
In addition, practices can use the free educational videos on the WellVet website to learn how the symptoms of perimenopause can be managed through lifestyle adjustments.
Alternatively you might like to just share the link to the WellVet Menopause Resources page with your team, allowing individuals to explore the information at their own pace.
Liz Barton, Director of WellVet, said: “Creating an open and understanding environment around health topics like perimenopause is crucial for the well-being of our teams.
“While perimenopause is a natural life stage, symptoms and long-term effects of hormonal changes adversely affect a significant portion of the workforce, yet it is a topic that is rarely discussed.
"There is growing interest from veterinary teams about how to start this conversation and provide peer support.
"We hope that by highlighting World Menopause Awareness Day, we can encourage colleagues in the veterinary community to take a moment to explore these resources to help individuals and foster a more supportive culture.”
https://www.wellvet.co.uk/resources/menopause-resources-for-veterinary-teams/
The research was carried out by scientists from Wisdom Panel, a pet DNA testing company that is part of Mars Petcare’s Science & Diagnostics division.
The discovery was made by analysing clinical data from Banfield Pet Hospital paired with DNA data from Wisdom Panel.
The researcher say estimates suggest canine atopic dermatitis affects up to 10-30% of dogs, and that these findings could lead to more targeted solutions in the future.
In addition, identification of the SLAMF1 variant presents the opportunity for breeders to breed toward dogs with a lower risk of atopic dermatitis.
Jimmy Barr, DVM, DACVECC, Chief Medical Officer for Mars Petcare’s Science & Diagnostics division said: “This finding could have a real impact on dog health
"While atopy has long been suspected to have a genetic component, this is the first time the SLAMF1 gene has been convincingly linked to this debilitating skin condition.
"This knowledge will help identify dogs at risk and could lead to new therapies and more informed dog breeding practices.”
Wisdom Panel has developed a DNA test that will be offered in partnership with Canine Genetic Testing at the Department of Veterinary Medicine, University of Cambridge so breeders can make informed decisions to reduce the frequency of atopic dermatitis while maintaining genetic diversity.
Reference
https://www.cagt.co.uk/
Photo: https://depositphotos.com
The awards are an opportunity to acknowledged unsung heroes within the veterinary profession, celebrating those who have made significant contributions to veterinary science, research, clinical practice, education and the welfare of small animals.
The award categories are:
Nominations are welcome from both BSAVA members and non-members.
Nominations will close on 9th January 2026 and the winners will be announced in February 2026.
Adam Gow, BSAVA Honorary Secretary said: “Each year, we’re proud to shine a spotlight on individuals who have truly made a difference in our profession.
"Nominating a colleague is a meaningful way to show appreciation and celebrate the impact they’ve had, so we encourage everyone to get involved and put forward those who inspire them.”
https://www.bsava.com/awards
Sarah qualified as an RVN in 2008, and has since had a varied career within veterinary nursing – gaining experience in both clinical and non-clinical roles, with small animals and wildlife, and in primary care and referral settings.
She is currently the senior oncology nurse at a large referral hospital in Surrey.
In her inaugural speech as President at the BVNA AGM, Sarah introduced her presidential theme of compassion and empathy, explaining how she wants to ensure the voice of veterinary nurses is “recognised, respected and represented” not just within veterinary clinics, but across the wider profession and society.
She said: "Compassion and empathy will mean something different to each of us.
"Personally, this theme really aligns with my role as an oncology RVN, whether that is supporting an owner through end-of-life care, hand feeding an inpatient, or making a colleague a cup of tea during a difficult shift.
“I believe this theme showcases the holistic nature of RVNs.
"We embed compassion in every part of our roles and it is at the heart of all we do.
"My vision is that this theme enables us to highlight the impact veterinary nurses have on our patients, their families and those within the profession.
"I am sure we all have an example of when a veterinary nurse’s compassion has made a real difference to someone’s life.
“I hope we can use this opportunity to recognise those that have demonstrated exceptional empathy and compassion within their role, and act as a reminder to show compassion to ourselves whilst working within the veterinary profession.”
The three factsheet chapters cover understanding OA, creating a management plan and supporting pets and their owners.
Krka says each section is grounded in evidence-based approaches and was shaped by Professor Carmichael’s extensive knowledge of the pathogenesis of pain in patients with OA and experience in the diagnosis, contextualised treatment, and long-term care of patients with OA.
The resources encourage veterinary teams to adapt their approach to the needs of each case - supporting a flexible, patient-centred mindset in everyday consults.
Stuart said: “What works is the thing that works best for the dog, the owner and the practice in that moment.
“And part of the art is trying to get that right rather than being dogmatic about a certain type of treatment.”
Renzo Di Florio, Krka’s Technical Veterinary Adviser, said: “In first-opinion practice, consult time is limited and there’s a lot to cover.
"These factsheets bring together expert advice in a format that’s quick to reference and easy to apply in consults.
"They’re designed to help vets feel more confident in their approach to OA, especially when time is tight.”
To further support veterinary professionals in managing OA, Professor Carmichael has delivered a webinar, available here: https://membership.elearning.vet/rethinking-canine-oa-login.
He and Renzo will also be presenting together at the London Vet Show this November, delivering a session focused on osteoarthritis in practice on Thursday 20th November at 14.00 in Exhibitor Showcase Theatre 2.
The OA factsheets are available here: https://www.krka.co.uk/veterinary-knowledge-hub/
Marketed since 2016, Thyronorm is an award-winning liquid formulation that simplifies administration compared to tablets and enables precise dosing for both veterinary surgeons and pet owners.
During the product handover veterinary practices can continue to buy Thyronorm from their usual wholesaler, and all practice support activities and retrospective commercial rebates remain unchanged.
Virbac says it is working closely with Norbrook to make sure all practice support activities are smoothly handed over from Norbrook Account Managers to Virbac Territory Managers.
https://uk.virbac.com
To help practices engage with pet owners on the topic, Animalcare has developed a collection of educational waiting room display materials, social posts and a national competition for the best practice-to-client dental communication.
For the competition, practices are invited to submit photos of their waiting room display and/or social media videos which show how Plaqtiv+ dental care products are used as part of a home oral hygiene routine.
Each element counts as an entry, so submitting a video and a photo of a practice waiting room display counts as two entries for the prize draw to win a Nespresso coffee machine and pods worth £180.
Submit your entries to animalcare@animalcare.co.uk, including your name, practice name, practice postcode and photos of your waiting room display or a link to your social media video.
animalcare.co.uk/dentalhealthmonth
The award, which is sponsored by Zoetis, celebrates vets in the first eight years of their career who have shown outstanding care, dedication or success.
Nominees may have delivered exceptional care to a patient, made a positive contribution to their community or the wider veterinary profession, or shown their dedication to a cause.
Early career vets who are keen to demonstrate their ambition and dedication to the profession can also self-nominate for the award.
British Veterinary Association President Elizabeth Mullineaux said: “We know how hard all vets work to care for the UK’s animals and to protect both human and animal health and welfare.
"Our young and early career vets deserve to have their incredible work recognised and this award is an opportunity to highlight their compassion, skills and positive contribution to the profession.”
The winner will be announced on Thursday 16th October 2025 at the BVA Awards in London, where they will be awarded a prize package which includes £1,000, a year of free BVA membership and mentoring/engagement opportunity with Zoetis.
The deadline for entries is 9am on Monday 4th August 2025.
www.bva.co.uk/YVOTY
Photo: Last year's winner, David Charles.
The new resource is designed to help dog owners understand the risks of cancer, recognise the importance of early detection, and learn how HT Vista’s cancer detection device supports veterinary teams in screening suspicious masses.
It includes guidance on the early warning signs of cancer in dogs and explains how acting quickly can improve outcomes.
Dr Liron Levy-Hirsch, Veterinary Surgeon and Managing Director at HT Vista said: “We believe informed pet owners are key to driving earlier diagnosis.
"This new page is all about bridging the gap between innovative veterinary technology and the people it’s designed to support.
"By empowering pet owners with clear and trustworthy information, we hope to strengthen understanding of the diagnostic process, support clinical decision-making, and ultimately help more dogs receive timely treatment.”
www.ht-vet.com/petowners
The study is being conducted with pet owners and veterinary professionals to develop a greater understanding about how flea and tick treatments are used on cats and dogs.
It will involve two depth surveys to explore the type and format of treatments used, the frequency of application, where treatments are bought, what influences the choice of product, whether there is an awareness of ectoparasiticides’ environmental effect and what preventative steps the public and clinicians would take when using the treatments on animals in the future.
At a later stage, the research project will also include lab assessments of ectoparasiticide residues collected from companion animals to provide more information on their potential environmental impact.
It is hoped the research findings will help the veterinary profession develop the most appropriate approaches to ectoparasiticides in the future, and inform educational strategies to support owners with ‘responsible use’.
Project leader Professor Richard Wall from the University of Bristol, said: “This is an issue of considerable concern.
"Citizen science and laboratory research evidence is urgently needed so that risk-based assessments of the impact of and requirements for ectoparasite treatment can be made.
"Whilst we can make some assumptions around the impact of routine ectoparasite treatments, these findings are essential for us to truly understand them - and to be able to balance the needs of veterinary patients with their wider environmental impacts.”
https://forms.office.com/e/mbztbYf4Ru.